<DOC>
	<DOCNO>NCT03103867</DOCNO>
	<brief_summary>The study open label single centre randomise cross study evaluate impact sensor augment pump ( SAP ) predictive algorithm suspend temporarily insulin administration ( 640G® Smart Guard feature ) versus use pump insulin administration 'only ' continuous glucose measurement ( interact pump , Freestyle Libre ® ) time glucose target , hypo- hyperglycemia . Exploratory endpoint effect sleep quality life child type 1 diabetes caregiver .</brief_summary>
	<brief_title>QUality Control slEep Children With diabeteS , Using New Technology</brief_title>
	<detailed_description>Optimising metabolic control child Type 1Diabetes Mellitus ( T1DM ) essential prevent late complication . Fear nocturnal hypoglycemia pervasive amongst parent child T1DM , lead heighten vigilance parent control regularly child 's blood sugar value check sensor information night . This lead chronic sleep interruption lack sleep well parent child diabetes . In study , impact new technology glucose time target , hypo fear quality life evaluate , use continuous interstitial glucose measurement either direct impact insulin administration ( 640G medtronic pump ( R ) ) alert , without impact insulin administration without alert .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 1 diabetes Duration diabetes ≥ 6 month Insulin pump treatment ≥ 6 month HbA1c ≤ 11 % Parental write informed consent . No parental consent Physical psychological disease likely interfere appropriate conduct study Current drug therapy know interfere glucose metabolism Chronic sleep medication primary caregiver patient</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>